The recent advancements in xenotransplantation, particularly the successful transplantation of a genetically modified pig kidney into a human patient, have opened up new frontiers in the field of organ transplantation. With over 100,000 Americans waiting for organ transplants and a severe shortage of human donors, scientists have turned to alternative solutions, such as genetically engineered pig organs, to save lives.
The groundbreaking clinical trial, which involved six patients receiving pig-to-human kidney transplants, aims to determine the safety and efficacy of using gene-edited pig organs as a replacement for failing human organs. This approach represents a significant shift from previous efforts to grow human organs inside animals, which were met with ethical concerns and regulatory restrictions.
While the concept of using pig organs for transplantation is not new, recent advancements in genetic engineering have made it possible to create organs that closely mimic human tissue, reducing the risk of rejection by the recipient’s immune system. However, challenges remain, as evidenced by a recent case where a gene-edited pig kidney had to be removed due to declining function.
Researchers are exploring various strategies to overcome the rejection issue, including modifying pig organs with human genes and developing immunosuppressive drugs to prevent rejection. Another promising approach involves growing organs from a patient’s own cells inside animal embryos, creating genetically matched organs that are less likely to be rejected.
Despite the potential benefits of using genetically engineered pig organs for transplantation, ethical concerns persist. The decision to ban the insertion of human stem cells into animal embryos in 2015 was driven by fears of blurring the line between human and animal and the potential for altering the cognitive state of the animal. Policymakers and animal advocacy groups raised concerns about the moral status of chimeras and the implications of granting them human-like awareness.
However, the logic behind the NIH’s ban on human-animal chimeras is flawed, as it fails to consider the broader ethical implications of species membership and cognitive capacities. The focus on self-consciousness as a determinant of moral status overlooks the diverse range of sentient beings and the varying degrees of harm they may experience.
In conclusion, the field of xenotransplantation holds great promise for addressing the critical shortage of organ donors and saving countless lives. As researchers continue to explore innovative approaches to organ transplantation, it is essential to consider the ethical implications and moral responsibilities associated with using genetically engineered pig organs. By striking a balance between scientific progress and ethical considerations, we can pave the way for a future where organ transplantation is more accessible and sustainable. Regulators play a crucial role in protecting all humans from harmful research practices, not because of their specific cognitive capacities, but simply because they are human beings. The moral concern stems from the inherent relationship between researchers and the subjects of their studies, rather than the subjects’ ability to feel pain, use language, or engage in abstract reasoning. It is the duty of regulators to ensure that the most basic interests of human beings are not violated in the pursuit of scientific advancement.
For example, if a pig embryo were to be infused with human cells to the point where it resembled a member of the human species, current research regulations would mandate that it be treated with human-level regard. However, the mere presence of human cells does not automatically grant the pig human status. This can be seen in the case of pigs engineered for kidney transplants, which already carry human genes but are not considered half-human beings. Similarly, when a person donates a kidney to another human, the recipient does not become part of the donor’s family.
While there may be valid reasons to object to using animals as living organ factories, such as welfare concerns, the notion that human cells could make pigs too human is based on a misunderstanding of what gives beings moral standing. It is essential to recognize that the presence of human cells does not fundamentally alter the nature of an animal.
In conclusion, regulators must uphold ethical standards in research to ensure that the rights and interests of all beings involved are respected. By considering the inherent relationship between researchers and subjects, rather than focusing solely on cognitive capacities, regulators can effectively safeguard the well-being of all individuals involved in scientific studies.
By Monika Piotrowska, Associate Professor of Philosophy, University at Albany, State University of New York
This article was republished from The Conversation under a Creative Commons license. Read the original article.
